Le Lézard
Classified in: Health
Subject: PER

Life Time Appoints James LaValle Chief Science Officer


LaValle to advance scientific strategies and initiatives as part of Life Time's revolutionary MIORA longevity and performance program and clinic

CHANHASSEN, Minn., April 29, 2024 /PRNewswire/ -- Life Time (NYSE: LTH) today announced the appointment of James LaValle, clinical pharmacist, C.C.N.M.T. as Chief Science Officer. LaValle will spearhead the development and implementation of scientific initiatives and strategic relationships to support MIORA, Life Time's new longevity and performance program launched in late 2023, including the first dedicated MIORA clinic at Life Time Target Center in Minneapolis.

An internationally recognized clinical pharmacist, author, board-certified clinical nutritionist and educator in integrative and precision health, LaValle brings more than 38 years of experience working in metabolic health issues, anti-aging research and advanced proactive patient care management to this new position. In partnership with MIORA's team of doctors, physician assistants, nurses, dieticians and health and wellness experts, LaValle's priorities include:

"We are unrelenting in our commitment to deliver the best personalized, science-backed approaches that help our members improve their health and live longer and better, and I'm thrilled to expand the relationship we've enjoyed with Jim for nearly 15 years," said Ali Yanez, senior vice president, LifeSpa and MIORA. "Given his rich experience and deep understanding of metabolic health, longevity, performance and beyond, we will continue to advance innovative tools, technology and truly personalized approaches that help our clients benefit from evidence-based solutions as opposed to the pervasive hype and sensationalism surrounding these topics today."

MIORA delivers an extensive range of proactive, personalized services for health, wellness, performance, and longevity:

Additionally, for appropriate candidates, MIORA offers peptides, including GLP-1s, which are showing to have the potential to change the landscape of weight management and obesity treatment. These will be offered in conjunction with integrated, personalized fitness, nutrition and total wellness programs with the objectives of weight loss, preserving lean body mass and improving overall health.

LaValle is best known for his expertise in personalized integrative therapies, uncovering the underlying metabolic issues that keep people from feeling healthy and vital, and as a thought leader in drug and nutrient depletion issues. He has served as an adjunct faculty member at the University of Cincinnati College of Pharmacy and the College of Medicine as well as serving as a preceptor. Additionally, he serves as the clinical co-chair at the American Academy of Anti-Aging Medicine and Chair of the International Peptide Society. As part of his dedication to exploring and advancing metabolic health, he has authored more than 24 books and four databases in the area of natural and integrative therapies.

For more information about MIORA, visit here.

About Life Time®
Life Time (NYSE: LTH) empowers people to live healthy, happy lives through its portfolio of more than 170 athletic country clubs across the United States and Canada. The health and wellness pioneer also delivers a range of healthy way of life programs and information via its complimentary Life Time Digital app. The Company's healthy living, healthy aging, healthy entertainment communities and ecosystem serve people 90 days to 90+ years old and is supported by a team of more than 37,000 dedicated professionals. In addition to delivering the best programs and experiences through its clubs, Life Time owns and produces nearly 30 of the most iconic athletic events in the country.

SOURCE Life Time, Inc.


These press releases may also interest you

at 20:00
Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, today announced the appointment of Mark S. de Jong, PhD, to the newly created position of Chief Technical Officer (CTO). Dr. de Jong, joins Full-Life with 43...

at 19:20
Whitman-Walker Institute, which leverages research, policy, and education to advance health equity nationwide, says it's standing by to further inform the chair of the U.S. House Committee on Education and the Workforce and others about the strong...

at 18:50
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against Akero Therapeutics, Inc....

at 18:46
Amgen today announced that the U.S. Food and Drug Administration (FDA) has approved IMDELLTRAtm (tarlatamab-dlle) for the...

at 18:42
Housecall Providers, a nonprofit home-based medical organization invites the community to Sellwood Park, Saturday, June 1, from noon ? 4:00 p.m. for an inspiring afternoon of learning, connection and some friendly competition. Toss...

at 18:30
BioSyent Inc. ("BioSyent", TSX Venture: RX) released today its financial results for the three months (Q1) ended March 31, 2024. Key highlights include:  (CAD)Q1 2024% Change vs.Q1 2023Trailing Twelve Months(TTM) March 31, 2024% Change vs.TTMMarch...



News published on and distributed by: